{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:04:42Z","timestamp":1790661882563,"version":"4.1.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.01999","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T03:16:35Z","timestamp":1597893395000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Mumps Vaccines: Current Challenges and Future Prospects"],"prefix":"10.3389","volume":"11","author":[{"given":"Iman","family":"Almansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/aje\/kwu014","article-title":"Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data","volume":"179","author":"Abrams","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.12688\/f1000research.16454.1","article-title":"Large-scale analysis of B-cell epitopes of envelope: implications for Zika vaccine and immunotherapeutic development","volume":"7","author":"Almansour","year":"2018","journal-title":"F1000Res."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"103982","DOI":"10.1016\/j.meegid.2019.103982","article-title":"MMRdb: measles, mumps, and rubella viruses database and analysis resource","volume":"75","author":"Almansour","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1700796","DOI":"10.2807\/1560-7917.ES.2018.23.25.1700796","article-title":"Resurgence risk for measles, mumps and rubella in France in 2018 and 2020","volume":"23","author":"B\u00e9raud","year":"2018","journal-title":"Euro Surveill."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/infdis\/174.3.619","article-title":"The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease","volume":"174","author":"Brown","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/0264-410X(91)90223-S","article-title":"Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients","volume":"9","author":"Brown","year":"1991","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3181\/00379727-123-31599","article-title":"Live attenuated mumps virus vaccine. 1. Vaccine development","volume":"123","author":"Buynak","year":"1966","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3181\/00379727-125-32278","article-title":"Comparison of neutralization and hemagglutination-inhibition techniques for measuring mumps antibody","volume":"125","author":"Buynak","year":"1967","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref9","first-page":"1528","article-title":"Mumps virus","volume-title":"Fields virology","author":"Carbone","year":"2007"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa1703309","article-title":"Effectiveness of a third dose of MMR vaccine for mumps outbreak control","volume":"377","author":"Cardemil","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref11","volume-title":"Mumps surveillance: January 1972\u2013June 1974","year":"1974"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/1045-1056(90)90009-O","article-title":"Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus","volume":"18","author":"Christenson","year":"1990","journal-title":"Biologicals"},{"key":"ref13","first-page":"302","article-title":"Aseptic meningitis after vaccination against measles and mumps","volume":"8","author":"Cizman","year":"1989","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref14","first-page":"311","article-title":"Mumps virus reinfection-clinical findings and serological vagaries","volume":"5","author":"Crowley","year":"2002","journal-title":"Commun. Dis. Public Health"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.meegid.2013.12.005","article-title":"Epidemiologic and genetic characteristics of mumps viruses isolated in China from 1995 to 2010","volume":"21","author":"Cui","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e0169561","DOI":"10.1371\/journal.pone.0169561","article-title":"Mumps epidemiology and mumps virus genotypes circulating in mainland China during 2013-2015","volume":"12","author":"Cui","year":"2017","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0168-1702(00)00254-9","article-title":"Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein","volume":"74","author":"Cusi","year":"2001","journal-title":"Virus Res."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clim.2004.12.010","article-title":"Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children","volume":"115","author":"Dhiman","year":"2005","journal-title":"Clin. Immunol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/oxfordjournals.aje.a010239","article-title":"Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs","volume":"151","author":"Dourado","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/s0140-6736(89)90822-2","article-title":"Mumps vaccine and meningitis","volume":"334","author":"Ehrengut","year":"1989","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1016\/S0264-410X(03)00341-4","article-title":"Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life","volume":"21","author":"Gans","year":"2003","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1086\/323346","article-title":"Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months","volume":"184","author":"Gans","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref23","first-page":"511","article-title":"A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age","volume":"30","author":"Gatchalian","year":"1999","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/00365549609027163","article-title":"An outbreak of mumps in a population partially vaccinated with the Rubini strain","volume":"28","author":"Germann","year":"1996","journal-title":"Scand. J. Infect. Dis."},{"key":"ref25","first-page":"29","article-title":"Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells","volume":"65","author":"Gl\u00fcck","year":"1986","journal-title":"Dev. Biol. Stand."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2807\/esm.03.12.00101-en","article-title":"Outbreak of mumps associated with poor vaccine efficacy - Oporto Portugal 1996","volume":"3","author":"Goncalves","year":"1998","journal-title":"Euro Surveill."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1086\/588195","article-title":"Immune responses to mumps vaccine in adults who were vaccinated in childhood","volume":"197","author":"Hanna-Wakim","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJM196802012780501","article-title":"Live, attenuated mumps-virus vaccine","volume":"278","author":"Hilleman","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0140-6736(08)60419-5","article-title":"Mumps","volume":"371","author":"Hviid","year":"2008","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1699-0463.1986.tb02112.x","article-title":"Cell-mediated and humoral immunity to mumps virus antigen","volume":"94","author":"Hy\u00f6ty","year":"1986","journal-title":"Acta Pathol. Microbiol. Immunol. Scand. C."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jmv.1890130403","article-title":"Immune responses to live attenuated and inactivated mumps virus vaccines in seronegative and seropositive young adult males","volume":"13","author":"Ilonen","year":"1984","journal-title":"J. Med. Virol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1086\/521029","article-title":"Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination","volume":"196","author":"Jokinen","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"18914.","DOI":"10.2807\/ese.13.26.18914-en","article-title":"Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype","volume":"13","author":"Kaaijk","year":"2008","journal-title":"Euro Surveill."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.1128\/JVI.78.16.8630-8640.2004","article-title":"Characterization of nucleocapsid binding by the measles virus and mumps virus phosphoproteins","volume":"78","author":"Kingston","year":"2004","journal-title":"J. Virol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jmb.2007.12.080","article-title":"Structure of the nucleocapsid-binding domain from the mumps virus polymerase; an example of protein folding induced by crystallization","volume":"379","author":"Kingston","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1006\/bbrc.2001.4764","article-title":"C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha","volume":"283","author":"Kubota","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1128\/JVI.79.7.4451-4459.2005","article-title":"Mumps virus V protein antagonizes interferon without the complete degradation of STAT1","volume":"79","author":"Kubota","year":"2005","journal-title":"J. Virol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1016\/j.vaccine.2008.05.060","article-title":"Immunogenicity and safety of a novel formalin-inactivated and alum-adjuvanted candidate subunit vaccine for mumps","volume":"26","author":"Liang","year":"2008","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/vim.2013.0135","article-title":"Conserved peptides containing overlapping CD4+ and CD8+ T-cell epitopes in the H1N1 influenza virus: an immunoinformatics approach","volume":"27","author":"Lohia","year":"2014","journal-title":"Viral Immunol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.15585\/mmwr.mm6701a7","article-title":"Recommendation of the advisory committee on immunization practices for use of a third dose of mumps virus\u2013containing vaccine in persons at increased risk for mumps during an outbreak","volume":"67","author":"Marin","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1016\/j.vaccine.2008.04.075","article-title":"Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006","volume":"26","author":"Marin","year":"2008","journal-title":"Vaccine"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s10156-011-0358-3","article-title":"Antibodies against mumps virus component proteins","volume":"18","author":"Matsubara","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1099\/0022-1317-48-2-395","article-title":"Morphological heterogeneity in relation to structural and functional properties of mumps virus","volume":"48","author":"McCarthy","year":"1980","journal-title":"J. Gen. Virol."},{"key":"ref45","author":"Medynicin","year":"2003"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/oxfordjournals.aje.a120248","article-title":"An epidemiologic study of mumps: its spread in schools and families","volume":"75","author":"Meyer","year":"1962","journal-title":"Am. J. Hyg."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/aje\/kwk045","article-title":"Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom","volume":"165","author":"Miller","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/0140-6736(93)91069-X","article-title":"Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/s0140-6736(89)92004-7","article-title":"Mumps vaccine complications: which strain?","volume":"2","author":"Nalin","year":"1989","journal-title":"Lancet"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jinf.2004.10.001","article-title":"Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population","volume":"51","author":"Ong","year":"2005","journal-title":"J. Inf. Secur."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1128\/JVI.64.9.4137-4145.1990","article-title":"RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts","volume":"64","author":"Paterson","year":"1990","journal-title":"J. Virol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/s0140-6736(86)91044-5","article-title":"Frequency of true adverse reactions to measles- mumps-rubella vaccine. A double-blind placebo-controlled trial in twins","volume":"1","author":"Peltola","year":"1986","journal-title":"Lancet"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/00006454-200104000-00004","article-title":"Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools","volume":"20","author":"Richardson","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e862","DOI":"10.1542\/peds.2006-3451","article-title":"Effectiveness of previous mumps vaccination during a summer camp outbreak","volume":"120","author":"Schaffzin","year":"2007","journal-title":"Pediatrics"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00006454-199103000-00008","article-title":"Aseptic meningitis as a complication of mumps vaccination","volume":"10","author":"Sugiura","year":"1991","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/viro.1996.0583","article-title":"The mumps virus SH protein is a membrane protein and not essential for virus growth","volume":"225","author":"Takeuchi","year":"1996","journal-title":"Virology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/0264-410X(92)90044-K","article-title":"Nasal antibody response to mumps virus after vaccination and natural infection","volume":"10","author":"Tanaka","year":"1992","journal-title":"Vaccine"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.1128\/JVI.77.11.6385-6393.2003","article-title":"STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling","volume":"77","author":"Ulane","year":"2003","journal-title":"J. Virol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/BF02962367","article-title":"Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children","volume":"26","author":"Usonis","year":"1998","journal-title":"Infection"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1651-2227.1983.tb09661.x","article-title":"Comparison of the Urabe am 9-Schwarz and Jeryl Lynn-Moraten combinations of mumps-measles vaccines in young children","volume":"72","author":"Vesikari","year":"1983","journal-title":"Acta Paediatr. Scand."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1128\/JVI.80.4.1700-1709.2006","article-title":"Function of small hydrophobic proteins of paramyxovirus","volume":"80","author":"Wilson","year":"2006","journal-title":"J. Virol."},{"key":"ref62","year":"2014"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1128\/JVI.02778-13","article-title":"Immunogenicity of novel mumps vaccine candidates generated by genetic modification","volume":"88","author":"Xu","year":"2014","journal-title":"J. Virol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.virol.2011.05.003","article-title":"Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus","volume":"417","author":"Xu","year":"2011","journal-title":"Virology"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s12519-019-00286-8","article-title":"Establishment of an efficient reverse genetic system of mumps virus S79 from cloned DNA","volume":"15","author":"Zhou","year":"2019","journal-title":"World J. Pediatr."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01999\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T19:08:07Z","timestamp":1667934487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.01999\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":65,"alternative-id":["10.3389\/fmicb.2020.01999"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.01999","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"article-number":"1999"}}